Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02715284
Title A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors (GARNET)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

endometrial cancer

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

Dostarlimab-gxly

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.